KOL Data

Sales & Marketing

As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.

Partner Content

how to navigate through KOL insights & management

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.